Whole-cell patch-clamp recordings

FA Fumiko Arima-Yoshida
MR Matthieu Raveau
AS Atsushi Shimohata
KA Kenji Amano
AF Akihiro Fukushima
MW Masashi Watanave
SK Shizuka Kobayashi
SH Satoko Hattori
MU Masaya Usui
HS Haruhiko Sago
NM Nobuko Mataga
TM Tsuyoshi Miyakawa
KY Kazuhiro Yamakawa
TM Toshiya Manabe
request Request a Protocol
ask Ask a question
Favorite

Whole-cell patch-clamp recordings were made from pyramidal cells in the CA1 region38. A recording patch pipette (3–6 MΩ) was filled with the internal solution containing (in mM): 122.5 K-gluconate, 17.5 KCl, 10.0 HEPES, 0.2 EGTA, 2.0 MgATP, 0.3 Na3GTP and 8.0 NaCl (pH 7.2, 295–305 mOsm). The series resistance and the input resistance were monitored throughout the experiment, and if they changed by more than 20% or the series resistance was above 30 MΩ, the data were discarded. A bipolar tungsten stimulating electrode was placed in the same layer as in the field-potential recording. Cells were held at − 60 mV (the liquid-junction potential was not corrected) and AMPA receptor-mediated EPSCs were recorded, which were adjusted to be 200–300 pA in amplitude. When GABAB receptor-dependent IPSCs were recorded, picrotoxin (100 µM) was added to the external solution. After recording stable EPSCs for 10 min, non-N-methyl-d-aspartate (NMDA)-receptor antagonist CNQX (10 µM) and the NMDA-receptor antagonist d-(−)-2-amino-5-phosphonopentanoic acid (50 µM) were added, and the GABAB receptor-mediated IPSC was recorded for further 10 min. The amplitude of GABAB receptor-mediated IPSCs was measured by averaging the value for 10 ms around the peak. In some experiments, we confirmed that the isolated IPSCs were blocked completely by CGP55845 (not shown).

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A